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ABSTRACT 
We report a case ofhyperphosphatasemia in a 35-year old patient with hepatitis B who 
underwent an orthotopic xenograft liver transplant. Marked elevations in total alkaline 
phosphatase [ALP: orthophosphoric monoester phosphohydrolase (alkaline optimum); Ee: 
3.1.1.1] activity beginning five days post-transplantation (six times human normal) and increasing 
to approximately seventeen times normal at day 11 was observed. Elevated ALP persisted for 
more than 40 days then steadily increased up to seventy-five times normal in the last 30 days. 
Gel electrophoresis detected both liver (LALP) and biliary (high-molecular mass, BALP) isoforms. 
LALP measured with ion-exchange columns revealed an activity time course pattern similar to 
that of total ALP. Results for BALP also obtained with use of ion-exchange columns exhibited 
varying amounts of activity ranging from two to four hundred and twenty-eight times normal. 
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INTRODUCTION 
Advances in surgical technique, organ preservation and immunosuppression have . 
made orthotopic liver transplantation an accepted form of therapy for patients with 
several acute and chronic end-state diseases (.1.=.5.). Recently, surgeons at the University 
of Pittsburgh Medical Center performed a cross-species history-making transplantation 
(xenotransplant) of a baboon liver into a 35 year old man who survived 70 days after the 
procedure (41.. 
In xenotransplants, as well as allotransplants, clinicians rely heavily on biochemical 
assays to assess the patient's status. A variety of serum markers such as hepatic enzymes (1), 
apolipoproteins (.8.), total bilirubin, delta and conjugated bilirubin (2.), and ketone body ratios 
{acetoacetic acid (AA) to beta-hydroxybutryic acid (HBA)} (lQ.) have been proposed to 
monitor liver grafts. However, no markers so far have not been sufficiently specific and 
sensitive to adequately monitor allograft function (11). Their value is xenotransplants 
has not been defined. 
In this case report we describe biochemical changes seen in a patient (6) who underwent 
baboon-to-human liver transplantation. We also describe the use of a mini-column ion-
exchange separation technique for the isolation and quantitative measurement of the biliary (high-
molecular-mass, BALP) isoform and liver alkaline phosphatase (LALP) isoform .. 
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PATIENT 
A 35 year old man with B virus-associated chronic active ~epatitis and human immuno-
deficiency virus infection was referred to our hospital due to a deteriorating condition relating 
to liver failure. Hepatitis B is considered by members of the transplantation community to be 
relative contraindication for human liver transplantation because of the great likelihood the 
disease will recur in transplanted liver. Xenotransplantation was performed with hopes that 
the baboon liver would be resistant to hepatitis B infection (.6.). 
Liver replacement was performed using the liver from a 15 year old male baboon (Papio 
Cynocephalus) using a "piggy-back" surgical technique (6.). The immunosuppression 
regimen included FK 506, methyl-prednisolone, prostaglandin, as well as daily non-myelotoxic 
doses of cyclophosphamide. The early post-operative course was uneventful. The 
patient was able to eat and ambulate by post-operative liay five. The baboon liver (600 grams) 
rapidly regenerated to the size of a human liver (1,555 grams) by day 24. Products of hepatic 
synthesis, including clotting factors, quickly became those of baboon origin with no obvious 
adverse effects. The remainder of his clinical course was complicated by short episodes of 
bacteremia, viremia, and candidal and cytomegalovirus esophagitis. Liver biopsies obtained 
on post-operative days 12, 24, 55 and 65 revealed increasing cholestasis and only minimal to 
mild acute cellular or humoral rejection. 
Biochemical monitoring was remarkable only for ALP which began to rise five days post-
transplant and plateaued at levels ten to twenty times normal from post-operative day 10 
through 40. On post-operative day 40, ALP began to rise again but the patient continued 
to do well. On post-operative day 61, the patient underwent percutaneous cholangiogram to 
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investigate the rise in ALP. Shortly after the cholangiogram which was read as normal, 
the patient became septic. This was followed by an abrupt deterioration of liver function 
and increases in hepatic enzymes. 
He remained in critical condition until his death on post-operative day 70 following 
subarachnoid hemorrhage associated with disseminated angioinvasive fungal infection. At 
autopsy biliary sludge, composed of precipitated bile and cellular debris, was found to occupy 
the entire intrahepatic biliary tree. The biliary mucosa was focally necrotic and multiple bile 
infarcts were present throughout the liver. The choledochojejunostomy was intact and patent. 
There was no histopathologic evidence of rejection at necropsy. 
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MATERIALS AND METHODS 
Samples: Serum samples from the patient were obtained daily after surgery. All samples were 
stored at -70 C. Day 0 was defined as the day of surgery. A single blood sample (Red Top) 
was taken at the same hour of the day for 70 days. Conventional biochemical markers for liver 
function (AST, ALT, GGT, Bilirubin, Total ALP) were assayed using a Kodak Ektachem 
Analyzer 700 (Eastman Kodak Co., Rochester, NY 14654). Ketone Body AAlHBA ratios 
were determined with arterial samples using the Ketorex Kit (Sanwa Chemical Company) 
Nagoya, Japan) and a KETO-340 semi-automatic spectrophotometer (Iharadenshi Company, 
Kasugai, Japan). 
Electrophoresis: ALP isoform electrophoresis was performed utilizing the AlkPhor poly-
acrylamide stacking gel (30 gIL) and running gel (70 gIL) combination system (Quantimetrix, 
Hawthorne, CA 90250-3115). Isoforms were identified on the basis of their electrophoretic 
mobility. Samples (25 uL) were applied to the top of the polymerized stacking gel and 
electrophoresis was conducted for 80 minutes at 3 rnA per tube with the Tris-boric acid 
buffer system and the use ofan analytical vertical-gel apparatus (Canalco, Rockville, MD. 
20852). Gels were removed from the glass tubes and stained for about 30 minutes at 
37 C with the ALP substrate, 5-bromo-4-chloro-3-indoylphosphate p-toluidine salt. After 
completion of staining which resulted in the development of blue bands, the staining solution 
was drained off and the tubes were filled with 5% acetic acid to stop the reaction. 
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Anion-Exchange (DEAD Sepharose) Chromatographic Separation of Alkaline 
Phosphatase Isoforms (Liver and Biliary): ALP isoforms were isolated by a procedure 
recently described for separation of mucin type glycoproteins (12). We applied 25 uL of serum 
to the top of a 7 mm X 45 mm column (Instrumentation Industries, Pittsburgh, Pa 15102) filled 
to a height of 6 mm with DEAE Sepharose (pharmacia Fine Chemicals, Piscataway, NJ 08854), 
and collected the sample effluent in the first fraction (Figure 1). Subsequent fractions were 
collected after stepwise elution with Tris HCI (5 mnlOl/L) containing, successively 100 and 150 
nunol of sodium chloride (PH 8.0) at 25 C. We collected one fraction of the 100 mrnollL 
sodium chloride buffer (2500 uL, Fraction 1) two fractions of the 150 mrnol/L sodium chloride 
buffer (2000 uL, Fraction 2 and 4000 uL, Fraction 3) and one fraction of the 300 mrnollL sodium 
chloride buffer (2000 uL, Fraction 4). Excellent recoveries of total alkaline phosphatase 
activity from the column (Fraction 1 to 4) were obtained; analytical recoveries averaged 98% 
(n=16). ALP isoforms in the column eluates were identified by electrophoresis on poly-
acrylamide gel (Figure 2). No carry-over ofLALP into BALP (Fraction 4) or BALP into 
Fraction 1 (LALP) was detected following electrophoretic analysis of column fractions 1 and 4. 
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Measurement of Liver and Biliary ALP Isoform Activity: Liver isoform (about 95%) was 
eluted from the DEAE Sepharose column inFraction 1 and biliary isoforrn (100%) was eluted 
in the high salt Fraction 4 in a manner similar to several column procedures described previously 
(13,14). Alkaline phosphatase activity was determined by a kinetic procedure (Beckman 
Instruments Inc., Carlsbad, CA 92008-4836) with p-nitrophenyl phosphate as substrate. 
A Cobas Fara automatic spectrophotometer (Roche Diagnostics Systems, Montclair, NJ) 
set at 405 mn was utilized to quantitate the concentration of isoforrns in column fractions. 
The between-run CV's for BALP and LALP in a control sera were 10.3% (mean 98 U/L, 
n=lO) and 5.7% (mean 597 UIL, n=lO) respectively. The within-run CV's in another 
control sera for BALP and LALP were 4.7% (mean 338 UIL, n=12), and 5.8% (mean 
4781 UIL, n=12, respectively. 
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RESULTS 
After transplantation the concentrations of most analytes were generally within 
the reference range for humans (6.). Special attention was given to liver function tests 
and other tests such as albumin, uric acid, cholesterol and total ALP whose normal ranges 
have been previously shown to be markedly divergent in the baboon and human (li). 
In general albumin averaged 25% lower than normal human, uric acid < 30 umolfL, 
cholesterol averaged 50% lower than normal and total ALP averaged 10 to 20 times 
higher than normal. At day 45 post-operative the results were as follows: Albumin, 1.9 gIL 
(human normal 3.5-5.0 gIL), uric acid less than 30 umolfL (human normal, 150-410 umolfL), 
cholesterol 1.71 mmolfL (human normal, 3.9-6.5 mmolfL) and total ALP, 2812 UIL (human 
normal, up to 125 UIL. 
Table 1 summarizes results of conventional liver function tests (AST, ALT, GGT, 
Total ALP, and bilirubin) obtained on six days (day 1,5,11,20,40 and 60) during the 
xenograft's time course of 70 days. Abnormal and increasing total ALP was observed at day 
5 (six times normal), day 11 (seventeen times normal) and day 60 (seventy-one times 
normal). However, in contrast abnormal but decreasing concentrations were demonstrated 
for AST, ALT and GGT during the immediate post-operative period followed by normal 
amounts throughout most of the post-operative course until day 40 when slightly increasing 
concentrations were observed. Bilirubin exhibited a similar pattern of abnormal but 
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decreasing concentrations except for a slight rise in concentration (up to 4.0 mgldL) at day 
25 with return to a decreasing concentration pattern from day 35 to 55. Time course plots 
for the entire time period (day 1 to 70) are shown in Figures 3A,3B,4A,4B and 4C. 
Arterial ketone body ratios (AAlHBA) were monitored for the first 30 days and results 
for days 1, 5 and 11 are shown in Table 1. The ratio rose from 0.45 at day 1 (poor 
prognosis) to 1.5 at day 5 and values near 1.0 (good prognosis) were observed subsequently. 
Previously, arterial blood ketone body ratios have been shown to reflect NADINADH 
concentrations within the hepatic mitochondria and these ratios appeared to provide reliable 
prognostic information with regard to early functional capacity of liver allografts (lQ) 
Gel electrophoresis of samples obtained every fourth day revealed only liver and biliary 
ALP isoforms with no detectable bone or intestinal isoform activity. Initially the LALP 
isoform band was single and sharp (up to day 5) but soon changed to multi-diffuse bands 
with slightly increased migration rates similar to ALP isoform bands observed in donor 
baboon sera. Representative sketches of gel electrophoretic patterns from a healthy 
individual, a donor baboon and xenograft patient at day 5 are shown in Figure 5 along with 
a gel photograph of the xenograft patient at day 15. 
LALP quantitatively measured by anion-exchange column chromatography (Fraction 1) 
revealed a time course activity pattern similar to total ALP (Figure 6A). Results for BALP 
also obtained with the use of the same anion-exchange column (Fraction 4) demonstrated 
unique activity patterns (Figure 6B) with significantly greater times normal elevations as 
compared to LALP (Figure 7A and 7B). 
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DISCUSSION 
Although orthotopic liver transplantation is now a well-established surgical procedure, 
complications still occur and early detection of these complications can be difficult. To assist 
in the detection of early complications conventional liver markers such as bilirubin, total ALP, 
GGT and transaminase (AST and AL T) are currently in widespread use. Unfortunately, 
these markers lack optimal sensitivity and specificity. 
Here, we report changes in ALP isoforms following baboon to human liver transplantation. 
During the first 40 days, unexplainable troughs and peaks of elevated BALP isoform (Range, 2 to 
90 times normal activity) were shown to precede the elevation of AST, ALT and GGT by 55 
days and bilirubin by 16 days. Although bilirubin concentrations were abnormal during the first 20 
days, they were decreasing in a manner typical of post-liver transplant patients. Thus, bilirubin 
concentrations during this time course were not considered alarming until the observed rise in 
bilirubin at day 20. 
Marked increases in total ALP and LALP isoform activities occurred shortly after 
BALP (2 days) with considerably less maximum times normal activity levels of25 and 20 for 
Total ALP and LALP, respectively. Evidence that our xenograft patient was indeed 
experiencing a biliary disorder during this early post-operative time period was shown by 
biopsy at day 12 which revealed mild biliary stasis and no evidence of rejection. The 
several peaks and troughs ofBALP activity observed here are, however not fully under-
stood at this time. 
Yeh et al (lA) have recently found serum BALP to be a specific marker in a 
variety of liver disorders. An ion-exchange column BALP procedure similar to the one 
described here was utlized and results exhibited 
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abnormal activity in three liver disorders; primary hepatocellular carcinoma, 
secondary metastatic liver tumors and obstructive jaundice. BALP was absent in healthy 
carriers of hepatitis B virus and in patients with non·hepatobiliary diseases. Although BALP 
activities were detectable in some cases of liver cirrhosis and chronic hepatits, these values 
were generally low. 
Yeh's group (M) also observed bilirubin insensitivity to biliary stasis and they 
speculate that only limited amounts of viable biliary treee are necessary 
to clear bilirubin efficiently, thus making it a poor test for early·stage biliary complications. 
This situation appears to have occurred in the xenograft patient i.e., unremarkable bilirubin 
concentration as well as hepatic enzymes AST, AL T and GGT despite biopsy-detectable biliary 
stasis during the early time course and widespread biliary sludge in the biliary tract as detected 
at autopsy (2). 
Lott (.16) using isoelectric focusing techniques to separate ALP isoforms, has also recently 
noted the clinical value of ALP isoforms as early indicators of complications in liver 
transplantation. Interestingly, Lott has suggested that abnormal ALP isoforms such as BALP 
actually precede biopsy-detectable rejection or biliary tree complications. 
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We suggest that BLAP release into the circulation is related to the detergent action 
of concentrated bile near the cell surface as previously reported in patients with cholestasis 
of the liver (11). A more extensive study to evaluate the clinical utility ofBALP isoform 
as an early indicator of rejection, infection or biliary tree related complications in patients 
undergoing human othotopic liver transplantation is now being planned. 
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TABLE 1 SERUM LIVER FUNCTION TESTS 
Sample Day Total Total AST ALT GGT AAlHBA 
ALP Bilirubin 
UIL MgldL UIL UIL UIL 
Donor Baboon 387 <0.1 54 23 36 *ND 
Patient (Pre-Op) 15 158 3.7 102 47 56 *ND 
Patient (post-Op) 1 155 12.7 205 139 49 0.45 
5 784 9.5 180 72 43 l.52 
11 2035 4.7 28 36 55 0.87 
20 2693 l.3 22 24 64 *ND 
40 3512 2.4 31 58 90 *ND 
60 7246 7.4 113 136 225 *ND 
Normal Up to 125 l.0 40 40 65 0.70 
Human Range 
*ND: Not Done 
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FIGURE LEGENDS 
Ion-Exchange Column Chromatographic Separation ofLALP and BALP 
Isoforms. 
Gel Electrophoresis of Column Isolated ALP Isoforms 
Left side (Fraction 1, LALP); Right side (Fraction 4, BALP) 
Time Course for Total Bilirubin (3A) and Total Alkaline Phosphatase (3B) 
After Baboon Liver Transplant 
Time Course for AST (4A), ALT (4B), and GGT (4C) After Baboon Liver 
Transplant 
Typical Gel ALP Electrophoretic Isoform Patterns for Human, Baboon, and 
Xenograft Patient 
Left Side (Schematic Diagram); Right Side (Gel Photograph) 
Time Course Results for LALP and BALP (Activity) After Baboon Liver 
Transplant 
Time Course 
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FOOTNOTES 
Nonstandard abbreviations: ALP, alkaline phosphatase~ AST, aspartate aminotransferase; 
ALP, alanine aminotransferase; GGT, gamma glutamyltransferase; AA, acetoacetic acid; 
HBA, beta-hydroxybutryic acid; BALP, biliary isofonn of alkaline phosphatase; LALP, 
liver isofonn of alkaline phosphatase. 
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